Izalontamab brenitecan shows promising activity in previously treated EGFR mutated NSCLC
Izalontamab brenitecan shows promising activity in previously treated EGFR mutated NSCLC
Political prioritisation as a driver of vaccine introduction: Evidence from Nigeria’s HPV rollout
Multilevel factors shaping blinatumomab delivery across diverse LMICs
Zidesamtinib shows promising efficacy in TKI-naïve ROS1-positive advanced NSCLC
Isa-VRd shows sustained benefit in transplant-ineligible newly diagnosed multiple myeloma
Subcutaneous tarlatamab shows encouraging efficacy in previously treated extensive-stage SCLC
Pembrolizumab plus chemotherapy shows pathological responses in resectable pleural mesothelioma
Image-defined risk factors predict surgical outcomes in paediatric neuroblastic tumours
Subcutaneous tarlatamab shows promising safety and activity in previously treated extensive-stage SCLC
Transcriptome-Wide Association Study identifies genetic factors linked to subsequent cancers in childhood cancer survivors
Cemiplimab shows strong survival benefit in KRAS G12C positive advanced NSCLC
Challenges in doing clinical research in the LATAM region